Viet Nam Securities Depository and Clearing Corporation (VSDC) would like to announce the record date of corporate action processing for the Securities registering institution as follows:

- Execution rate: 1 share - 1 voting right
- Meeting time:  31/03/2026
- Meeting venue: Danapha Pharmaceutical Joint Stock Company (Lot A22, Street No. 3, Da Nang High-Tech Park, Lien Chieu Ward, Da Nang City)
- Tentative Meeting agenda:
- Summary report of the Board of Directors for 2021-2026 term and announcement of the end of 2021-2026 term of the Board of Directors;
- Report of the Board of Directors on 2025 corporate governance;
- Report of the CEO on 2025 results of production and business activities and 2026 operational plan;
- Report on the progress of the Pharmaceutical Manufacturing Plant Project and the High-Tech Research and Development Center;
- Report on the progress of the Office and Tourist Apartment Project;
- Report on 2025 results of transactions with related parties;
- Report on 2025 activities of the Supervisory Board;
- Proposal for approving 2025 audited financial statements;
- Proposal for approving 2025 profit distribution plan, fund allocation, earnings reserved for fund establishment in 2025 and 2026 projected financial targets;
- Proposal for approving the selection of auditing firm for the 2026 fiscal year;
- Proposal for approving the report on 2025 remuneration payments to the Board of Directors, Supervisory Board, CEO, and the Company's Secretary and 2026 payment plan;
- Proposal for approving the number of members of the Board of Directors and Supervisory Board for the 2026 – 2031 term;
- Election of members of the Board of Directors and Supervisory Board for 2026 – 2031 term;
+ Other related issues within the authority of the General meeting (if any);
Coordination details and procedures for corporate action processing for holders of the above securities between VSDC, the Securities registering institution and depository members are specified in the Guideline on corporate action processing for securities holders at VSDC
Danapha Pharmaceutical Joint Stock Company and the parties involved in the process of preparing the dossier, documents of corporate action processin are fully responsible before the law for the legality, accuracy, truthfulness and completeness of the dossier; Institutions and individuals participating in the confirmation of records and documents shall be legally responsible within the scope related to such records and documents as prescribed in Clause 1, Article 11a of the Securities Law No. 54/2019/QH14 dated 26/11/2019, supplemented by Clause 4, Article 1 of Law No. 56/2024/QH15 dated 29/11/2024.